A Feasibility study of Pemetrexed single agent and folic acid given as neoadjuvant treatment in patients with resectable rectal cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-005929-62

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the feasibility of three neo-adjuvant cycles of single agent Pemetrexed at 500 mg/m2 q3w prior to surgery with or without radiotherapy in patients with resectable rectal cancer.


Critère d'inclusion

  • neoadjuvant treatment in chemo-naive patients with newly diagnosed operable rectal cancer

Liens